Contact
searchSearch
HMP Global

Renal Denervation

Renal Denervation

Renal Denervation
TCT26: Renal Denervation with Medtronic Symplicity Shows Significant Blood Pressure Drops in SPYRAL AFFIRM Real-World Study
11/04/2026
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Nearly nine out of 10 patients...
11/04/2026
Cath Lab Digest
renal denervation
Paradise uRDN System Demonstrates 19.5 mmHg Blood Pressure Reduction at 12 Months, with Durability Through 4 Years
11/03/2026
Seven abstracts sponsored by Recor Medical presented at TCT 2026 highlight expanding clinical evidence for ultrasound renal denervation.
Seven abstracts sponsored by Recor Medical presented at TCT 2026 highlight expanding clinical evidence for ultrasound renal denervation.
Seven abstracts sponsored by...
11/03/2026
Cath Lab Digest
Renal Denervation
TIME Names Recor Medical’s Paradise Ultrasound Renal Denervation System One of the Best Inventions of 2026
10/15/2026
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal...
10/15/2026
Cath Lab Digest
Renal Denervation
Recor Medical Announces AMA CPT Editorial Panel Approval of Two New Category I CPT Codes for Renal Denervation
10/01/2026
The new codes, 37X47 and 37X48, describe percutaneous transcatheter renal sympathetic denervation procedures and are expected to become effective January 1, 2028.
The new codes, 37X47 and 37X48, describe percutaneous transcatheter renal sympathetic denervation procedures and are expected to become effective January 1, 2028.
The new codes, 37X47 and 37X48,...
10/01/2026
Cath Lab Digest
hypertension treatment
Building a Comprehensive Hypertension Program: A Multidisciplinary Approach to Renal Denervation
09/21/2026
Maria Carolina Delgado-Lelievre, MD; Iliana S. Hurtado-Rendón, MD
A conversation with Dr. Hurtado and Dr. Delgado from the University of Miami on patient selection, collaboration, and integrating ultrasound renal denervation into hypertension care.
A conversation with Dr. Hurtado and Dr. Delgado from the University of Miami on patient selection, collaboration, and integrating ultrasound renal denervation into hypertension care.
A conversation with Dr. Hurtado...
09/21/2026
Cath Lab Digest
Prevalence of hypercortisolism in resistant hypertension patients from the MOMENTUM Study – credit Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital
Resistant Hypertension
Nearly 30 Percent of Patients With Resistant Hypertension Have a Hormone Disorder Caused by High Cortisol
03/30/2026
MOMENTUM is described as the first U.S.-based study and the largest study to date to assess the prevalence of hypercortisolism among individuals with resistant hypertension. Researchers analyzed 1,086 participants across 50 centers in the...
MOMENTUM is described as the first U.S.-based study and the largest study to date to assess the prevalence of hypercortisolism among individuals with resistant hypertension. Researchers analyzed 1,086 participants across 50 centers in the...
MOMENTUM is described as the...
03/30/2026
Cath Lab Digest
Renal Denervation
Medtronic Reports Positive 3-Year SPYRAL HTN Results and Launches EMBRACE Study for Symplicity Spyral
03/30/2026
The Expand Management of Blood pressure with Renal denervation in patients undergoing staged PCI for Advanced Coronary artery diseasE (EMBRACE) is a randomized, multicenter trial evaluating Symplicity Spyral™ renal denervation added to staged...
The Expand Management of Blood pressure with Renal denervation in patients undergoing staged PCI for Advanced Coronary artery diseasE (EMBRACE) is a randomized, multicenter trial evaluating Symplicity Spyral™ renal denervation added to staged...
The Expand Management of Blood...
03/30/2026
Cath Lab Digest
RDN & REIMBURSEMENT
Renal Denervation in Practice: A Conversation With Tai Kobayashi, MD
12/15/2025
Taisei J. Kobayashi, MD
"With CMS coverage finalized and private payers beginning to follow, renal denervation is poised to move from niche to mainstream," says Dr. Kobayashi. "The therapy’s safety profile is well established,(3,8) and now we have the infrastructure...
"With CMS coverage finalized and private payers beginning to follow, renal denervation is poised to move from niche to mainstream," says Dr. Kobayashi. "The therapy’s safety profile is well established,(3,8) and now we have the infrastructure...
"With CMS coverage finalized and...
12/15/2025
Cath Lab Digest
ultrasound renal denervation
Latest Real-World Clinical Data Demonstrate a 19.6 mmHg Reduction in Blood Pressure at 6 Months with Recor Medical’s Paradise Ultrasound Renal Denervation System
10/30/2025
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE Clinical Trial Program Demonstrates a 15.7...
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE Clinical Trial Program Demonstrates a 15.7...
Data Presented at the 2025 TCT...
10/30/2025
Cath Lab Digest
Renal Denervation
CMS Issues National Coverage Determination for Recor Medical’s Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
10/29/2025
Recor Medical, Inc., News Palo Alto, Calif. – Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that the Centers for Medicare and Medicaid Services (CMS) has issued its National Coverage...
Recor Medical, Inc., News Palo Alto, Calif. – Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that the Centers for Medicare and Medicaid Services (CMS) has issued its National Coverage...
Recor Medical, Inc.,...
10/29/2025
Cath Lab Digest
Resistant Hypertension
Paradise™ Ultrasound Renal Denervation in Contemporary Practice
10/03/2025
Behnam N. Tehrani, MD, FSCAI
"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...
"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...
"The signal has been important...
10/03/2025
Cath Lab Digest

Joachim Weil, MD
RF RDN
SPYRAL HTN-OFF and -ON MED 24-Month Results: BP Reductions After RF RDN
04/02/2025
Joachim Weil, MD
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a...
04/02/2025
Cath Lab Digest
Jeremy Bock, MD
Renal Denervation
Blood Pressure Response Following Radiofrequency Renal Denervation in a Large Commercial U.S. Cohort
03/21/2025
Jeremy S. Bock, MD, FACC, FSCAI
Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...
Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...
Dr. Jeremy Bock discusses his...
03/21/2025
Cath Lab Digest
Michael J. Bloch headshot
Meeting Update
Updates from TCT 2023: Renal Denervation
11/22/2023
Michael J. Bloch, MD
Michael J. Bloch, MD, discusses hypertension and a patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials.
Michael J. Bloch, MD, discusses hypertension and a patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials.
Michael J. Bloch, MD, discusses...
11/22/2023
Journal of Invasive Cardiology
Escaned and Sandoval
CT-Guided PCI at TCT 2026
Reactions to the International Randomized P4 (Precise Procedural and PCI Plan) Trial
11/06/2026
Javier Escaned, MD, PhD; Yader Sandoval, MD
Professors Javier Escaned and Yader Sandoval, interventional cardiologists experienced in CT-guided PCI, share their thoughts on the P4 trial.
Professors Javier Escaned and Yader Sandoval, interventional cardiologists experienced in CT-guided PCI, share their thoughts on the P4 trial.
Professors Javier Escaned and...
11/06/2026
Cath Lab Digest
Nicole Dellise and Derek Pineda
For the CV Team
The Importance of Publishing — and Pathways to Follow — For the CV Team
11/05/2026
Nicole Dellise, DNP, FNP-BC, NEA-BC, CHFN, CCK, FACC; Derek Pineda, FNP, CCRN, RCIS
Nicole Dellise, DNP, and Derek Pineda, FNP, describe their recent publication encouraging cardiovascular team members to publish and the importance of sharing their work with the broader community.
Nicole Dellise, DNP, and Derek Pineda, FNP, describe their recent publication encouraging cardiovascular team members to publish and the importance of sharing their work with the broader community.
Nicole Dellise, DNP, and Derek...
11/05/2026
Cath Lab Digest
Derek Pineda, FNP, CCRN, RCIS
TCT Nurse & Technologist Symposium
Beyond the Stent: Metal-Free Coronary Revascularization
11/05/2026
Derek Pineda, FNP, CCRN, RCIS
Derek Pineda, FNP, CCRN, RCIS, AACC, shares thoughts from his presentation on drug-coated balloons at the TCT Nurse and Technologist Symposium, which took place in San Diego, California, on October 31, 2026. 
Derek Pineda, FNP, CCRN, RCIS, AACC, shares thoughts from his presentation on drug-coated balloons at the TCT Nurse and Technologist Symposium, which took place in San Diego, California, on October 31, 2026. 
Derek Pineda, FNP, CCRN, RCIS,...
11/05/2026
Cath Lab Digest
Cristina Valdez MSN ACNP
TCT Nurse & Technologist Symposium
Calcium Modification at TCT's Nurse & Technologist Symposium
11/02/2026
Cristina Valdez, MSN, ACNP
Cristina Valdez, MSN, ACNP, presented "Cursed Vessels: Navigating the Nightmare of Coronary Calcification" at the October 31st Nurse and Technologist session at TCT 2026 in San Diego, California.
Cristina Valdez, MSN, ACNP, presented "Cursed Vessels: Navigating the Nightmare of Coronary Calcification" at the October 31st Nurse and Technologist session at TCT 2026 in San Diego, California.
Cristina Valdez, MSN, ACNP,...
11/02/2026
Cath Lab Digest
Drs Escaned and Sandoval
Expert Discussion: Video & Podcast
Driving the Evolution of CT-Guided PCI: From CT Planning to Live Procedural Guidance
10/26/2026
Javier Escaned, MD, PhD; Yader Sandoval, MD
A discussion by interventional cardiologists: Professors Javier Escaned and Yader Sandoval share their perspectives on the evolving role of CT-guided PCI and the innovations shaping the future of PCI planning and guidance.
A discussion by interventional cardiologists: Professors Javier Escaned and Yader Sandoval share their perspectives on the evolving role of CT-guided PCI and the innovations shaping the future of PCI planning and guidance.
A discussion by interventional...
10/26/2026
Cath Lab Digest
STEMI: The Stakes, with Dr. Sameer Mehta
CRT 2026
Every Second Counts: The Critical Role of Nurses & Techs in Beating the Balloon Clock
05/18/2026
Sameer Mehta, MD, FACC, MBA
"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
"STEMI: The Stakes": A video presentation by Sameer Mehta, MD, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.
"STEMI: The Stakes": A video...
05/18/2026
Cath Lab Digest
Brian C. Case, MD, and Bailey Ann Richardson, MSN, AGNP
Coronary Microvascular Dysfunction
Coronary Microvascular Dysfunction for Cath Lab Staff
02/25/2026
Brian C. Case, MD; Bailey Ann Richardson, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
Bailey Richardson, MSN, speaks...
02/25/2026
Cath Lab Digest
Matthew H. Gonzalez, MD
VIDEO: Heart Failure
CardioMEMS™ HF System: Advancing Heart Failure Care Through Collaboration With General Cardiology
02/11/2026
Matthew H. Gonzalez, MD
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute video...
02/11/2026
Cath Lab Digest
Philips OBL / ASC Video
Brief Overview
Out-of-Hospital (OBL/ASC) Trends and Landscape
11/19/2025
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that...
11/19/2025
Cath Lab Digest
Interview With Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Videos
Prevalence of Atrial Fibrillation Increases Major Adverse Cardiovascular Events, Particularly Heart Failure Hospitalization in Patients With Peripheral Arterial Disease
11/18/2025
Viet Le, PA-C, FACC, FAHA; Isabel Vega
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS,...
11/18/2025
EP Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Renal Denervation
TCT26: Renal Denervation with Medtronic Symplicity Shows Significant Blood Pressure Drops in SPYRAL AFFIRM Real-World Study
11/04/2026
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Nearly nine out of 10 patients...
11/04/2026
Cath Lab Digest
renal denervation
Paradise uRDN System Demonstrates 19.5 mmHg Blood Pressure Reduction at 12 Months, with Durability Through 4 Years
11/03/2026
Seven abstracts sponsored by Recor Medical presented at TCT 2026 highlight expanding clinical evidence for ultrasound renal denervation.
Seven abstracts sponsored by Recor Medical presented at TCT 2026 highlight expanding clinical evidence for ultrasound renal denervation.
Seven abstracts sponsored by...
11/03/2026
Cath Lab Digest
Renal Denervation
TIME Names Recor Medical’s Paradise Ultrasound Renal Denervation System One of the Best Inventions of 2026
10/15/2026
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal Denervation (uRDN) system has been recognized by TIME with a Best Inventions of 2026 award in the Medical and Healthcare category.
The Paradise™ Ultrasound Renal...
10/15/2026
Cath Lab Digest
Renal Denervation
Recor Medical Announces AMA CPT Editorial Panel Approval of Two New Category I CPT Codes for Renal Denervation
10/01/2026
The new codes, 37X47 and 37X48, describe percutaneous transcatheter renal sympathetic denervation procedures and are expected to become effective January 1, 2028.
The new codes, 37X47 and 37X48, describe percutaneous transcatheter renal sympathetic denervation procedures and are expected to become effective January 1, 2028.
The new codes, 37X47 and 37X48,...
10/01/2026
Cath Lab Digest
Prevalence of hypercortisolism in resistant hypertension patients from the MOMENTUM Study – credit Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital
Resistant Hypertension
Nearly 30 Percent of Patients With Resistant Hypertension Have a Hormone Disorder Caused by High Cortisol
03/30/2026
MOMENTUM is described as the first U.S.-based study and the largest study to date to assess the prevalence of hypercortisolism among individuals with resistant hypertension. Researchers analyzed 1,086 participants across 50 centers in the...
MOMENTUM is described as the first U.S.-based study and the largest study to date to assess the prevalence of hypercortisolism among individuals with resistant hypertension. Researchers analyzed 1,086 participants across 50 centers in the...
MOMENTUM is described as the...
03/30/2026
Cath Lab Digest
Renal Denervation
Medtronic Reports Positive 3-Year SPYRAL HTN Results and Launches EMBRACE Study for Symplicity Spyral
03/30/2026
The Expand Management of Blood pressure with Renal denervation in patients undergoing staged PCI for Advanced Coronary artery diseasE (EMBRACE) is a randomized, multicenter trial evaluating Symplicity Spyral™ renal denervation added to staged...
The Expand Management of Blood pressure with Renal denervation in patients undergoing staged PCI for Advanced Coronary artery diseasE (EMBRACE) is a randomized, multicenter trial evaluating Symplicity Spyral™ renal denervation added to staged...
The Expand Management of Blood...
03/30/2026
Cath Lab Digest
ultrasound renal denervation
Latest Real-World Clinical Data Demonstrate a 19.6 mmHg Reduction in Blood Pressure at 6 Months with Recor Medical’s Paradise Ultrasound Renal Denervation System
10/30/2025
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE Clinical Trial Program Demonstrates a 15.7...
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE Clinical Trial Program Demonstrates a 15.7...
Data Presented at the 2025 TCT...
10/30/2025
Cath Lab Digest
Renal Denervation
CMS Issues National Coverage Determination for Recor Medical’s Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
10/29/2025
Recor Medical, Inc., News Palo Alto, Calif. – Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that the Centers for Medicare and Medicaid Services (CMS) has issued its National Coverage...
Recor Medical, Inc., News Palo Alto, Calif. – Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that the Centers for Medicare and Medicaid Services (CMS) has issued its National Coverage...
Recor Medical, Inc.,...
10/29/2025
Cath Lab Digest
Renal Denervation
Medtronic Receives Approval for Symplicity Spyral Renal Denervation System in Japan
09/02/2025
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure...
09/02/2025
Cath Lab Digest
RDN approvals
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
08/25/2025
The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is a...
08/25/2025
Cath Lab Digest
George Dangas, MD, PhD
Awards
George Dangas, MD, PhD, Receives the Most Coveted Award From the American Heart Association’s Council on Clinical Cardiology
11/09/2026
Laennec Master Clinician Award recognizes his lifetime achievements in cardiovascular patient care and cardiology education.
Laennec Master Clinician Award recognizes his lifetime achievements in cardiovascular patient care and cardiology education.
Laennec Master Clinician Award...
11/09/2026
Cath Lab Digest
Heart Failure
DETECT-HF Pivotal Study Validates Cordio Medical’s Smartphone-Based Voice Analysis for Remote Heart Failure Monitoring
11/09/2026
The 563-patient blinded study found that HearO predicted more than 70% of heart failure events at an average of 24.6 days before they occurred, with high patient compliance and no device-related adverse events.
The 563-patient blinded study found that HearO predicted more than 70% of heart failure events at an average of 24.6 days before they occurred, with high patient compliance and no device-related adverse events.
The 563-patient blinded study...
11/09/2026
Cath Lab Digest
Clinical Trials
Evolocumab Lowers Risk of Heart Attacks by 20% Compared With Ezetimibe in a Large Real-World Study
11/09/2026
Amgen announced results from a large real-world study showing that treatment with Repatha® (evolocumab) reduced the risk of fatal or nonfatal heart attacks by 20% compared with ezetimibe in people with atherosclerotic cardiovascular disease...
Amgen announced results from a large real-world study showing that treatment with Repatha® (evolocumab) reduced the risk of fatal or nonfatal heart attacks by 20% compared with ezetimibe in people with atherosclerotic cardiovascular disease...
Amgen announced results from a...
11/09/2026
Cath Lab Digest
Cardiogenic Shock
SCAI Updates Cardiogenic Shock Classification to Sharpen Recognition and Track Treatment Response
11/09/2026
2026 expert consensus reinforces assessment of perfusion and patient trajectory, with expanded guidance across shock populations and care settings.
2026 expert consensus reinforces assessment of perfusion and patient trajectory, with expanded guidance across shock populations and care settings.
2026 expert consensus reinforces...
11/09/2026
Cath Lab Digest
Clinical Trials
PARAMOUNT, the First Randomized Trial of AI-Enabled Plaque-Based Care, Meets Primary Endpoint in Late-Breaking Results at AHA 2026
11/09/2026
Compared with usual care based on stress testing, care guided by AI-based quantitative coronary CT analysis (AI-QCT) improved diagnostic certainty and led to more patients receiving lipid-lowering therapy.
Compared with usual care based on stress testing, care guided by AI-based quantitative coronary CT analysis (AI-QCT) improved diagnostic certainty and led to more patients receiving lipid-lowering therapy.
Compared with usual care based...
11/09/2026
Cath Lab Digest
Clinical Trials
DAPT-SHOCK-AMI: Cangrelor Associated With Greater Recovery of Heart Function in Cardiogenic Shock Imaging Substudy
11/09/2026
Patients with acute myocardial infarction complicated by cardiogenic shock who received intravenous cangrelor had less microvascular obstruction and greater recovery of left ventricular function than those receiving crushed oral ticagrelor,...
Patients with acute myocardial infarction complicated by cardiogenic shock who received intravenous cangrelor had less microvascular obstruction and greater recovery of left ventricular function than those receiving crushed oral ticagrelor,...
Patients with acute myocardial...
11/09/2026
Cath Lab Digest
FFR CT Analysis
CT-Guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
11/04/2026
Late-Breaking P4 study shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI planning decisions. NAVIGATE-PCI shows Heartflow PCI Navigator drove...
Late-Breaking P4 study shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI planning decisions. NAVIGATE-PCI shows Heartflow PCI Navigator drove...
Late-Breaking P4 study shows CT...
11/04/2026
Cath Lab Digest
Women and PE
SYMPHONY-PE IDE: First-in-Field Analysis Provides Encouraging Safety Findings for Women with Pulmonary Embolism
11/04/2026
Sub-analysis presented at TCT 2026 shows substantial clot burden reduction and improved right-heart function with the Symphony Thrombectomy System despite greater baseline cardiac stress in women
Sub-analysis presented at TCT 2026 shows substantial clot burden reduction and improved right-heart function with the Symphony Thrombectomy System despite greater baseline cardiac stress in women
Sub-analysis presented at TCT...
11/04/2026
Cath Lab Digest
Renal Denervation
TCT26: Renal Denervation with Medtronic Symplicity Shows Significant Blood Pressure Drops in SPYRAL AFFIRM Real-World Study
11/04/2026
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Nearly nine out of 10 patients experienced a clinical benefit at six months. Medtronic receives FDA approval for U.S. labeling update to Symplicity blood pressure procedure, expanding clinical evidence informing treatment options
Nearly nine out of 10 patients...
11/04/2026
Cath Lab Digest
TAVR
TAVR Use Increased Nearly Ninefold Among Patients Under 70 in Health System Analysis
11/04/2026
Annual TAVR procedures among patients younger than 70 rose from 15 in 2014 to 134 in 2024 within one health system, driven primarily by patients in their 60s, while surgery remained predominant.
Annual TAVR procedures among patients younger than 70 rose from 15 in 2014 to 134 in 2024 within one health system, driven primarily by patients in their 60s, while surgery remained predominant.
Annual TAVR procedures among...
11/04/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use